Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCW3E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,273
Award facts
- Contract value 100% obligated
- $26,273.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Beyfortus 50 mg/0.5 ml syringes with a ceiling value of $26,273.08 and a firm fixed price structure. This non-set-aside, competitively awarded contract represents a single delivery order with an ultimate completion date of December 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Beyfortus is a monoclonal antibody used for respiratory syncytial virus (RSV) prevention in infants and young children, indicating this procurement supports federal medical supply requirements for military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contracts with the Defense Logistics Agency and routinely fulfills critical medical commodity requirements across multiple therapeutic domains for the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCW3E?
SPE2DR26FCW3E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FCW3E worth?
The government has obligated $26,273 on SPE2DR26FCW3E.
Is contract SPE2DR26FCW3E an order under another contract?
Yes. SPE2DR26FCW3E is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCW3E competed?
The extent of competition for SPE2DR26FCW3E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award